No matter how many PIP’s you hand out, cut 50% of the sales force, rehire, retrain, restructure …. if you don’t address underlying concerns…sales will never come close to forecast. This product is not difficult to sell.
Voquezna has (on average) 87% commercial coverage. Issues filling prescriptions are wide spread as well as data not being reported. Sales reps are provided no pull through data for community pharma rx’s or blink rx. Instead this data is withheld by management. Voquezna should not be experiencing issues of this magnitude in terms of % fill. This cannot be fixed at a rep level.
Phathom is destroying the morale and focus of this sales force. Large scale PIP’s in general, create a sense of uneasiness for the entire sales force, not just lower performers. It causes the salesforce question the health and direction of the company. Large budget cuts, in the middle of a launch for our largest indication, make any relatively intelligent person, question the health of Phathom. This sales force should have every resource available to them, in a launch of this potential. This salesforce should feel confident in the direction of the company.
This salesforce is your lifeline to Voquezna sales. This sales force has the relationships with our physicians, offices, staff. Upper management has no relationships with providers. Bottom line- support your sales force. Listen to their suggestions.